These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12810354)

  • 1. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity.
    Park WH; Kim KS; Kim KH; Kim DS; Kim CH
    Int Immunopharmacol; 2003 Jul; 3(7):971-8. PubMed ID: 12810354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
    Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
    Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiplatelet activity of Danggijakyaksan by inhibition of phospholipase C.
    Park WH; Kim SH; Chang YC; Lee YC; Kim CH
    Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):561-71. PubMed ID: 14686798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.
    Sheu JR; Kan YC; Hung WC; Su CH; Lin CH; Lee YM; Yen MH
    Thromb Res; 1998 Oct; 92(2):53-64. PubMed ID: 9792112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
    Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
    J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
    Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
    J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits.
    Kim BJ; Kim YK; Park WH; Ko JH; Lee YC; Kim CH
    Int Immunopharmacol; 2003 May; 3(5):723-34. PubMed ID: 12757741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
    Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
    J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets.
    Sheu JR; Lee CR; Lin CH; Hsiao G; Ko WC; Chen YC; Yen MH
    Thromb Haemost; 2000 May; 83(5):777-84. PubMed ID: 10823277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for antiplatelet effect of onion: AA release inhibition, thromboxane A(2)synthase inhibition and TXA(2)/PGH(2)receptor blockade.
    Moon CH; Jung YS; Kim MH; Lee SH; Baik EJ; Park SW
    Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):277-83. PubMed ID: 10883058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
    Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
    Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
    Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T
    Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation.
    Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP
    Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
    Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis.
    Lee JJ; Jin YR; Lee JH; Yu JY; Han XH; Oh KW; Hong JT; Kim TJ; Yun YP
    Planta Med; 2007 Feb; 73(2):121-7. PubMed ID: 17410649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
    Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
    Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.